NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its third quarter revenues rose 5 percent year over year, driven by higher grant revenue and sales of women's health and molecular products.

For the three months ended Sept. 30, revenues increased to $49.3 million from $46.8 million in Q3 2015. However, reported revenues missed the average analyst expectation for revenues of $50.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.